Spero
1 known investors
Spero Therapeutics is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases, starting with SP001, a third-generation anti-CD40L antibody for IgG4-related disease. The company focuses on rheumatology and other immune-mediated conditions.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Spero do?
- Spero Therapeutics is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases, starting with SP001, a third-generation anti-CD40L antibody for IgG4-related disease. The company focuses on rheumatology and other immune-mediated conditions.
- Who are Spero's investors?
- Spero's investors include HEALTHCARE ROYALTY PARTNERS.